IMBdx has developed an innovative liquid biopsy platform known as AlphaLiquid®, which focuses on the early detection of cancer through advanced genomic and epigenomic analyses. This platform utilizes cutting-edge liquid biopsy technology to provide ultra-sensitive cancer diagnostic capabilities, enabling the identification of circulating tumor DNA (ctDNA) for various applications, including genomic profiling, monitoring of advanced cancer patients, and recurrence detection. The AlphaLiquid®100 test, in particular, is designed for real-time therapy response monitoring and to detect minimal residual disease (MRD) in post-operative patients, showcasing its robust performance validated through clinical studies.

The company’s offerings extend beyond diagnostics to include services that enhance clinical practice and biopharmaceutical research. IMBdx's solutions aim to improve treatment strategies by allowing healthcare providers to monitor patients in real-time and to facilitate the safety and efficiency of clinical trials. Their research initiatives focus on understanding tumor evolution and resistance mechanisms, thereby enriching translational research in precision oncology. Overall, IMBdx's technologies are positioned to significantly impact cancer care by providing comprehensive tools for early detection and ongoing patient management.

South Korea

IMB Dx is a precision oncology company focused on developing solutions for safe & accurate cancer diagnosis & monitoring. We created AlphaLiquid®, a minimally-invasive liquid biopsy method which requires only a single blood draw to detect cancer and monitor its progress. With AlphaLiquid®, we offer a comprehensive genomic profile of the tumor and matching therapies as well as clinical trial information.

Since we began our research in 2014, our goal has remained the same: to make cancer diagnosis accessible and affordable to as many cancer patients as possible. 

For more information, please visit us at www.imbdx.com/eng/ or contact us at support@imbdx.com.

IMBdx

Company Details